Pharmaceutical Literacy and Quality of Life in Spanish Population.
NCT ID: NCT06729697
Last Updated: 2025-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
1246 participants
OBSERVATIONAL
2024-11-15
2025-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Are patients abilities and knowledge about their medications sufficient to ensure a safe and efective use?
* Are those knowledge and abilities related to the patient's quality of life? How?
Patients already taking at least one medication will answer questions about their abilities and knowledge towards medication and their quality of life related to their health state.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Intervention to Reduce Medication Errors and Improve Adherence
NCT01291966
Integral Management of Healthcare Problems Related With Drugs in Polimedicated Patients: Medication Code
NCT03607097
Effects of a Clinical Pharmacist Service on Health-related Quality of Life
NCT01016301
Safe Use of Medication at Home by Caregivers. Experimental Study
NCT05247801
A Pharmaceutical Intervention to Reduce Drug-Related Problems in a Home Healthcare Program
NCT05820945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The participants selected are adults usually taking medication that answer questions related to their pharmaceutical literacy (RALPH interview). This type of literacy refers to three domains regarding functional, comunicative and critical abilities about their own medication.
After that, every participant answers a simple survey regarding their health-related quality of life including topics such as mobility, self-care, everyday activities, pain and mental health (EQ-5D-5L survey).
The recruitment and interviewing take place at the same time, and it requires less than 30 minutes per patient. No follow-up is needed afterward.
There are no risks associated with this procedure, and the participation of the patients will always be voluntary and anonymous.
Previously to the patients' enrollment in the study, proper information will be given to the potential participants and an informed consent will be signed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sociedad Espanola de Farmacia Clinica, Familiar y Comunitaria
OTHER
University of Barcelona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pilar Modamio
Full Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pilar Modamio Charles, PhD
Role: STUDY_DIRECTOR
University of Barcelona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Pharmacy and Pharmaceutical Care Unit.
Barcelona, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Roudijk B, Ludwig K, Devlin N. EQ-5D-5L Value Set Summaries. 2022 Mar 24. In: Devlin N, Roudijk B, Ludwig K, editors. Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide [Internet]. Cham (CH): Springer; 2022. Chapter 4. Available from http://www.ncbi.nlm.nih.gov/books/NBK589305/
Andreu-March M, Aguas Compaired M, Marino EL, Modamio P. Cross-cultural adaptation and validation of the Recognizing And Addressing Limited Pharmaceutical Literacy (RALPH) interview guide in community pharmacies. Res Social Adm Pharm. 2023 Jun;19(6):882-888. doi: 10.1016/j.sapharm.2023.02.004. Epub 2023 Feb 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CER052416
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.